0000899243-20-010341.txt : 20200406
0000899243-20-010341.hdr.sgml : 20200406
20200406193459
ACCESSION NUMBER: 0000899243-20-010341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200403
FILED AS OF DATE: 20200406
DATE AS OF CHANGE: 20200406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARTHELEMY NICOLAS
CENTRAL INDEX KEY: 0001283576
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 20778107
MAIL ADDRESS:
STREET 1: 1750 BELLA LAGUNA CT
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-03
0
0000730272
REPLIGEN CORP
RGEN
0001283576
BARTHELEMY NICOLAS
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2020-04-03
4
M
0
1652
42.07
A
6761
D
Common Stock
2020-04-03
4
S
0
2688
99.99
D
4073
D
Stock Option (Right to Buy)
42.07
2020-04-03
4
M
0
1652
0.00
D
2028-05-16
Common Stock
1652
1652
D
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on February 28, 2020.
This option is currently exercisable.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2020-04-06